These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26211901)

  • 1. Calculation of injection forces for highly concentrated protein solutions.
    Fischer I; Schmidt A; Bryant A; Besheer A
    Int J Pharm; 2015 Sep; 493(1-2):70-4. PubMed ID: 26211901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheological characterization and injection forces of concentrated protein formulations: an alternative predictive model for non-Newtonian solutions.
    Allmendinger A; Fischer S; Huwyler J; Mahler HC; Schwarb E; Zarraga IE; Mueller R
    Eur J Pharm Biopharm; 2014 Jul; 87(2):318-28. PubMed ID: 24560966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Injection Performance of a Tapered Needle for Use in Prefilled Biopharmaceutical Products.
    Krayukhina E; Fukuhara A; Uchiyama S
    J Pharm Sci; 2020 Jan; 109(1):515-523. PubMed ID: 31654659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer.
    Allahham A; Stewart P; Marriott J; Mainwaring DE
    Int J Pharm; 2004 Feb; 270(1-2):139-48. PubMed ID: 14726130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing injection force modeling and viscosity-dependent injectability evaluation for prefilled syringes.
    Wu L; Li H; Wang Y; Liu C; Zhao Z; Zhuang G; Chen Q; Zhou W; Guo J
    Eur J Pharm Biopharm; 2024 Apr; 197():114221. PubMed ID: 38378097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding syringeability and injectability of high molecular weight PEO solution through time-dependent force-distance profiles.
    Feng X; Wu KW; Balajee V; Leissa J; Ashraf M; Xu X
    Int J Pharm; 2023 Jan; 631():122486. PubMed ID: 36521635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery Considerations of Highly Viscous Polymeric Fluids Mimicking Concentrated Biopharmaceuticals: Assessment of Injectability via Measurement of Total Work Done "W
    Zhang Q; Fassihi MA; Fassihi R
    AAPS PharmSciTech; 2018 May; 19(4):1520-1528. PubMed ID: 29464592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectability as a function of viscosity and dosing materials for subcutaneous administration.
    Watt RP; Khatri H; Dibble ARG
    Int J Pharm; 2019 Jan; 554():376-386. PubMed ID: 30414478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions.
    Burckbuchler V; Mekhloufi G; Giteau AP; Grossiord JL; Huille S; Agnely F
    Eur J Pharm Biopharm; 2010 Nov; 76(3):351-6. PubMed ID: 20719247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation the injectability of injectable microparticle delivery systems on the basis of injection force and discharged rate.
    Zhao C; Zhu Z; Cao X; Pan F; Li F; Xue M; Guo Y; Zhao Y; Zeng J; Liu Y; Yang Z; Liu Y; Ren F; Feng L
    Eur J Pharm Biopharm; 2023 Sep; 190():58-72. PubMed ID: 37437667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature and consequences of protein-protein interactions in high protein concentration solutions.
    Saluja A; Kalonia DS
    Int J Pharm; 2008 Jun; 358(1-2):1-15. PubMed ID: 18485634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High shear rheology and anisotropy in concentrated solutions of monoclonal antibodies.
    Zarraga IE; Taing R; Zarzar J; Luoma J; Hsiung J; Patel A; Lim FJ
    J Pharm Sci; 2013 Aug; 102(8):2538-49. PubMed ID: 23873347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterile Filtration of Highly Concentrated Protein Formulations: Impact of Protein Concentration, Formulation Composition, and Filter Material.
    Allmendinger A; Mueller R; Huwyler J; Mahler HC; Fischer S
    J Pharm Sci; 2015 Oct; 104(10):3319-29. PubMed ID: 26149748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of a micro-capillary rheometer for in-vitro evaluation of parenteral injectability.
    Allahham A; Mainwaring D; Stewart P; Marriott J
    J Pharm Pharmacol; 2004 Jun; 56(6):709-16. PubMed ID: 15231035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheological behavior of xanthan gum solution related to shear thinning fluid delivery for subsurface remediation.
    Zhong L; Oostrom M; Truex MJ; Vermeul VR; Szecsody JE
    J Hazard Mater; 2013 Jan; 244-245():160-70. PubMed ID: 23246952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectability of biodegradable in situ forming microparticle systems (ISM).
    Rungseevijitprapa W; Bodmeier R
    Eur J Pharm Sci; 2009 Mar; 36(4-5):524-31. PubMed ID: 19124076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proximity energies: a framework for understanding concentrated solutions.
    Laue T
    J Mol Recognit; 2012 Mar; 25(3):165-73. PubMed ID: 22407980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear.
    Patapoff TW; Esue O
    Pharm Dev Technol; 2009; 14(6):659-64. PubMed ID: 19883255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filling the Gap: A Correlation between Objective and Subjective Measures of Injectability.
    Robinson TE; Hughes EAB; Bose A; Cornish EA; Teo JY; Eisenstein NM; Grover LM; Cox SC
    Adv Healthc Mater; 2020 Mar; 9(5):e1901521. PubMed ID: 31977153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectability evaluation: an open issue.
    Cilurzo F; Selmin F; Minghetti P; Adami M; Bertoni E; Lauria S; Montanari L
    AAPS PharmSciTech; 2011 Jun; 12(2):604-9. PubMed ID: 21553165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.